ArticlePloS one2022

CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata.

Andres Ceballos-Garzon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.